AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020HCV elimination in France. The countdown has startedView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Reduction of hepatitis C burden in Islamabad, Pakistan slums through CHW screen and treat programsView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Missed Opportunities for HCV Elimination in Provincial Correctional Institutions in Ontario, CanadaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Cost Effectiveness of expanding treatment with Direct Acting Antiviral treatment to reduce Hepatitis C incidence among HIV infected MSM in ThailandView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA seroconversion and genetically linked HCV infectionsView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Seroprevalence and associated risk factors for Hepatitis B virus infection among barbers and their clients in two cities of CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Healthcare consumption in addicted versus non-addicted hepatitis B and C patients in the NetherlandsView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Occult Hepatitis B Virus Infection among HIV negative and positive isolated anti-HBc individuals in Eastern EthiopiaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Toward Hepatitis B and hepatitis D elimination in CubaView Abstract
DBDavid BackPhDSlidesetHIVSalvador HIV Clinical Forum 2019Long Acting ARV: Drugs and Delivery Systems - David Back, PhDView Slideset
CBCarlos BritesMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2019Treatment Options for HIV-TB Co-Infection - Carlos Brites, MD, PhDView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019Time to Change the Paradigm: Two vs. Three Drugs - Estevão Nunes, MDView Slideset
